article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey.

article thumbnail

Chromatography analysis for nitrosamine quantitation in pharmaceutical manufacturing water

European Pharmaceutical Review

The authors noted that the observations were contextualised to “illustrate the amounts of nitrosamine that could be formed from process water during API and drug product manufacture”. Limiting nitrosamine formation The authors highlighted that wet granulation is commonly used to manufacture solid oral dosage forms.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Development of novel water-soluble inks for 3D-printed polypills

European Pharmaceutical Review

Benefits in manufacturing The authors illustrated MM-IJ3DP using a novel formulation of a soluble polymer, to enable for the first time, Noyes–Whitney release rates to be programmed and modulated through digital design and manufacture. Rivers et al. This paper features in the June 2024 issue of the journal Materials Today Advanced.

Dosage 98
article thumbnail

WuXi STA breaks ground on new Delaware manufacturing facility

European Pharmaceutical Review

Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. The biopharmaceutical industry is part of Delaware’s DNA,” stated Delaware Governor John Carney.

article thumbnail

COVID-19 underscores need to boost pharma manufacturing in emerging markets

pharmaphorum

The International Finance Corporation, the division of the World Bank Group that invests in the private sectors of emerging markets, has provided financing for several emerging market pharmaceutical manufacturers with the goal of boosting developing countries’ access to affordably priced drugs. About the author. Dr Subir K.

Vaccines 122
article thumbnail

FOPE and PharmaState Academy address HVAC Systems in pharma manufacturing

Express Pharma

On October 6, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy conducted Session 6 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on HVAC Systems and Qualification in pharmaceutical manufacturing. The session began with a keynote address by Thiru M.

Dosage 105
article thumbnail

FOPE and PharmaState Academy’s PULSE initiative delivers insights on water systems and qualification in pharma manufacturing

Express Pharma

The PULSE series continues to receive support from key industry associations, including CIPI, Laghu Udyog Bharati, Indian Pharma Machinery Manufacturers Association, Karnataka Drugs and Pharmaceuticals Manufacturers Association, and many more. Stay tuned for updates on the PULSE initiative and upcoming sessions.

Dosage 99